SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-008143
Filing Date
2017-05-05
Accepted
2017-05-05 15:34:26
Documents
26
Period of Report
2017-05-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plxp20170504_8k.htm 8-K 25190
2 EXHIBIT 23.1 ex23-1.htm EX-23.1 3418
3 EXHIBIT 99.1 ex99-1.htm EX-99.1 8547
4 EXHIBIT 99.2 ex99-2.htm EX-99.2 306199
5 EXHIBIT 99.3 ex99-3.htm EX-99.3 215104
6 slide20.jpg GRAPHIC 172400
7 slide19.jpg GRAPHIC 173546
8 slide18.jpg GRAPHIC 153725
9 slide17.jpg GRAPHIC 171381
10 slide16.jpg GRAPHIC 127788
11 slide15.jpg GRAPHIC 148080
12 slide14.jpg GRAPHIC 141694
13 slide13.jpg GRAPHIC 174811
14 slide12.jpg GRAPHIC 156793
15 slide11.jpg GRAPHIC 168360
16 slide10.jpg GRAPHIC 157173
17 slide9.jpg GRAPHIC 161435
18 slide8.jpg GRAPHIC 147727
19 slide7.jpg GRAPHIC 183688
20 slide6.jpg GRAPHIC 141309
21 slide5.jpg GRAPHIC 228313
22 slide4.jpg GRAPHIC 201042
23 slide3.jpg GRAPHIC 191199
24 slide2.jpg GRAPHIC 194618
25 slide1.jpg GRAPHIC 287511
26 slide0.jpg GRAPHIC 115485
  Complete submission text file 0001437749-17-008143.txt   5517092
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 17818164
SIC: 2834 Pharmaceutical Preparations